Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ranbaxy Reports Corrections At Dewas Plant To U.S. FDA; Hopes Import Restrictions Will Be Lifted Soon

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Part of Ranbaxy's troubles with its manufacturing units in India may be coming to an end in the next few months; the company has filed an exhaustive report with the U.S. FDA on corrections made at its manufacturing facilities at Dewas
Advertisement

Related Content

More Indian Sites Under U.S. FDA Lens? Wockhardt Slapped With Import Alert On Injectables Site
Daiichi Sankyo Goes After Generics In Japan, Forms New Company With Ranbaxy
Daiichi Sankyo Goes After Generics In Japan, Forms New Company With Ranbaxy
Will Teva's Deal With AstraZeneca Over Nexium Patents Erode Ranbaxy's Marketing Exclusivity In 2014?
Will Teva's Deal With AstraZeneca Over Nexium Patents Erode Ranbaxy's Marketing Exclusivity In 2014?
Ranbaxy Sees Better Days Ahead With The Launch Of Valtrex Generic In U.S.
Ranbaxy Sees Better Days Ahead With The Launch Of Valtrex Generic In U.S.
Ranbaxy In Bear Grip As Sales Slip In U.S. After FDA Restrictions
Ranbaxy In Bear Grip As Sales Slip In U.S. After FDA Restrictions
U.S. FDA Nails Ranbaxy On Charges Of Falsifying Data; Halts All Application Reviews From Paonta Sahib Plant
Advertisement
UsernamePublicRestriction

Register

SC072451

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel